These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37857130)

  • 41. A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
    Cortesi L; Baldassarri B; Ferretti S; Razzaboni E; Bella M; Bucchi L; Canuti D; De Iaco P; De Santis G; Falcini F; Galli V; Godino L; Leoni M; Perrone AM; Pignatti M; Saguatti G; Santini D; Sassoli de'Bianchi P; Sebastiani F; Taffurelli M; Tazzioli G; Turchetti D; Zamagni C; Naldoni C
    Cancer Med; 2020 Apr; 9(7):2579-2589. PubMed ID: 32045136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
    Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
    Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
    Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Yang AZY; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng RCH; Ong KW; Madhukumar P; Oey CL; Ho GH; Tan PH; Tan MH; Ang P; Yap YS; Lee ASG
    Oncotarget; 2018 Feb; 9(16):12796-12804. PubMed ID: 29560110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early breast cancer risk detection: a novel framework leveraging polygenic risk scores and machine learning.
    Tao LR; Ye Y; Zhao H
    J Med Genet; 2023 Oct; 60(10):960-964. PubMed ID: 37055164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of breast cancer risk for sisters of women attending screening.
    Mao X; He W; Eriksson M; Lindström LS; Holowko N; Bajalica-Lagercrantz S; Hammarström M; Grassmann F; Humphreys K; Easton D; Hall P; Czene K
    J Natl Cancer Inst; 2023 Nov; 115(11):1310-1317. PubMed ID: 37243694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
    Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR
    Breast Cancer Res; 2024 Jan; 26(1):2. PubMed ID: 38167144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
    Lonjou C; Eon-Marchais S; Truong T; Dondon MG; Karimi M; Jiao Y; Damiola F; Barjhoux L; Le Gal D; Beauvallet J; Mebirouk N; Cavaciuti E; Chiesa J; Floquet A; Audebert-Bellanger S; Giraud S; Frebourg T; Limacher JM; Gladieff L; Mortemousque I; Dreyfus H; Lejeune-Dumoulin S; Lasset C; Venat-Bouvet L; Bignon YJ; Pujol P; Maugard CM; Luporsi E; Bonadona V; Noguès C; Berthet P; Delnatte C; Gesta P; Lortholary A; Faivre L; Buecher B; Caron O; Gauthier-Villars M; Coupier I; Mazoyer S; Monraz LC; Kondratova M; Kuperstein I; Guénel P; Barillot E; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Int J Cancer; 2021 Apr; 148(8):1895-1909. PubMed ID: 33368296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among Asian Women.
    Yang Y; Tao R; Shu X; Cai Q; Wen W; Gu K; Gao YT; Zheng Y; Kweon SS; Shin MH; Choi JY; Lee ES; Kong SY; Park B; Park MH; Jia G; Li B; Kang D; Shu XO; Long J; Zheng W
    JAMA Netw Open; 2022 Mar; 5(3):e2149030. PubMed ID: 35311964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of patient age on breast cancer risk prediction models.
    Coopey SB; Acar A; Griffin M; Cintolo-Gonzalez J; Semine A; Hughes KS
    Breast J; 2018 Jul; 24(4):592-598. PubMed ID: 29316072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychological impact of providing women with personalised 10-year breast cancer risk estimates.
    French DP; Southworth J; Howell A; Harvie M; Stavrinos P; Watterson D; Sampson S; Evans DG; Donnelly LS
    Br J Cancer; 2018 Jun; 118(12):1648-1657. PubMed ID: 29736008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
    Brentnall AR; Cohn WF; Knaus WA; Yaffe MJ; Cuzick J; Harvey JA
    J Breast Imaging; 2019 Jun; 1(2):99-106. PubMed ID: 31423486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the contribution of lifestyle in breast cancer risk prediction: a systematic review of models applicable to Europe.
    Mertens E; Barrenechea-Pulache A; Sagastume D; Vasquez MS; Vandevijvere S; Peñalvo JL
    BMC Cancer; 2023 Jul; 23(1):687. PubMed ID: 37480028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study.
    Ohbe H; Hachiya T; Yamaji T; Nakano S; Miyamoto Y; Sutoh Y; Otsuka-Yamasaki Y; Shimizu A; Yasunaga H; Sawada N; Inoue M; Tsugane S; Iwasaki M;
    Breast Cancer Res Treat; 2023 Feb; 197(3):661-671. PubMed ID: 36538246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
    Roberts E; van Veen EM; Byers H; Barnett-Griness O; Gronich N; Lejbkowicz F; Pinchev M; Smith MJ; Howell A; Newman WG; Woodward ER; Harkness EF; Brentnall AR; Cuzick J; Rennert G; Howell SJ; Evans DG
    Genet Med; 2023 Sep; 25(9):100846. PubMed ID: 37061873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.
    Fasching PA; Bani MR; Nestle-Krämling C; Goecke TO; Niederacher D; Beckmann MW; Lux MP
    Eur J Cancer Prev; 2007 Jun; 16(3):216-24. PubMed ID: 17415092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women.
    Hou C; Xu B; Hao Y; Yang D; Song H; Li J
    BMC Cancer; 2022 Apr; 22(1):374. PubMed ID: 35395775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of a genetic risk score for Arkansas women of color.
    Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
    PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polygenic risk scores and breast cancer risk prediction.
    Roberts E; Howell S; Evans DG
    Breast; 2023 Feb; 67():71-77. PubMed ID: 36646003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.